Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Lecozotan
Другие языки:

Lecozotan

Подписчиков: 0, рейтинг: 0
Lecozotan
Lecozotan structure.svg
Identifiers
  • 4-Cyano-N-[(2R)-2-[4-(2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazinyl]propyl]-N-2-pyridinylbenzamide hydrochloride
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C28H30ClN5O3
Molar mass 520.03 g·mol−1
3D model (JSmol)
  • C[C@H](CN(C1=CC=CC=N1)C(=O)C2=CC=C(C=C2)C#N)N3CCN(CC3)C4=C5C(=CC=C4)OCCO5
  • InChI=1S/C28H29N5O3/c1-21(31-13-15-32(16-14-31)24-5-4-6-25-27(24)36-18-17-35-25)20-33(26-7-2-3-12-30-26)28(34)23-10-8-22(19-29)9-11-23/h2-12,21H,13-18,20H2,1H3/t21-/m1/s1
  • Key:NRPQELCNMADTOZ-OAQYLSRUSA-N
  (verify)

Lecozotan is an investigational drug by Wyeth tested for improvement of cognitive functions of Alzheimer's disease patients. As of June 2008, the first Phase III clinical trial has been completed.

Method of action

Lecozotan is a competitive, selective 5-HT1A receptor antagonist which enhances the potassium-stimulated release of acetylcholine and glutamate.



Новое сообщение